These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 17404112
1. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Yin Y, Ni J, Chen M, DiMaggio MA, Guo Y, Yeh S. Clin Cancer Res; 2007 Apr 01; 13(7):2271-80. PubMed ID: 17404112 [Abstract] [Full Text] [Related]
2. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Ni J, Mai T, Pang ST, Haque I, Huang K, DiMaggio MA, Xie S, James NS, Kasi D, Chemler SR, Yeh S. Clin Cancer Res; 2009 Feb 01; 15(3):898-906. PubMed ID: 19188160 [Abstract] [Full Text] [Related]
3. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects. Yin Y, Ni J, Chen M, Guo Y, Yeh S. Clin Cancer Res; 2009 Jan 01; 15(1):190-200. PubMed ID: 19118046 [Abstract] [Full Text] [Related]
4. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells. Chang E, Ni J, Yin Y, Lin CC, Chang P, James NS, Chemler SR, Yeh S. Asian J Androl; 2007 Jan 01; 9(1):31-9. PubMed ID: 17187157 [Abstract] [Full Text] [Related]
5. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells. Ni J, Pang ST, Yeh S. Prostate; 2007 Apr 01; 67(5):463-71. PubMed ID: 17252538 [Abstract] [Full Text] [Related]
6. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo. Liu B, Lee KW, Li H, Ma L, Lin GL, Chandraratna RA, Cohen P. Clin Cancer Res; 2005 Jul 01; 11(13):4851-6. PubMed ID: 16000583 [Abstract] [Full Text] [Related]
7. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA. Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K. Cancer Res; 2004 Jun 15; 64(12):4263-9. PubMed ID: 15205340 [Abstract] [Full Text] [Related]
8. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. Stewart LV, Weigel NL. Prostate; 2005 Jun 15; 64(1):9-19. PubMed ID: 15651061 [Abstract] [Full Text] [Related]
9. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Zhang M, Altuwaijri S, Yeh S. Oncogene; 2004 Apr 15; 23(17):3080-8. PubMed ID: 15048090 [Abstract] [Full Text] [Related]
10. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Yu W, Sanders BG, Kline K. Nutr Cancer; 1997 Apr 15; 27(1):92-101. PubMed ID: 8970189 [Abstract] [Full Text] [Related]
11. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, Birrer MJ, Sanders BG, Kline K. Mol Carcinog; 1997 Jul 15; 19(3):180-90. PubMed ID: 9254885 [Abstract] [Full Text] [Related]
12. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R. Cancer Epidemiol Biomarkers Prev; 2003 Sep 15; 12(9):933-9. PubMed ID: 14504208 [Abstract] [Full Text] [Related]
13. Vitamin E succinate promotes breast cancer tumor dormancy. Malafa MP, Neitzel LT. J Surg Res; 2000 Sep 15; 93(1):163-70. PubMed ID: 10945959 [Abstract] [Full Text] [Related]
14. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Israel K, Yu W, Sanders BG, Kline K. Nutr Cancer; 2000 Sep 15; 36(1):90-100. PubMed ID: 10798221 [Abstract] [Full Text] [Related]
15. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Cancer Res; 2004 Dec 01; 64(23):8715-22. PubMed ID: 15574782 [Abstract] [Full Text] [Related]
16. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA. Provenzano AP, Besner GE, James PF, Harding PA. Growth Factors; 2005 Mar 01; 23(1):19-31. PubMed ID: 16019424 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo. Devi GR, Sprenger CC, Plymate SR, Rosenfeld RG. Prostate; 2002 May 01; 51(2):141-52. PubMed ID: 11948969 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction. Massoner P, Haag P, Seifarth C, Jurgeit A, Rogatsch H, Doppler W, Bartsch G, Klocker H. Prostate; 2008 Aug 01; 68(11):1165-78. PubMed ID: 18459102 [Abstract] [Full Text] [Related]
19. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL, Lin JK. Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333 [Abstract] [Full Text] [Related]
20. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P. J Pathol; 2004 Jan 01; 202(1):50-9. PubMed ID: 14694521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]